Hunan Nucien Pharmaceutical Co (SHSE:688189) Institutional Ownership: 0.45% (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688189 Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
50 GF Score
Price ¥6.74
GF Value ¥2.30
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Hunan Nucien Pharmaceutical Co Institutional Ownership?

Hunan Nucien Pharmaceutical Co SHSE:688189 +1.81% 50 Institutional Ownership is 0.45% as of Aug. 31, 2026. GuruFocus rates SHSE:688189 with a GF Score™ of 50/100 and a GF Value™ of ¥2.30 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Hunan Nucien Pharmaceutical Co's institutional ownership is 0.45%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Hunan Nucien Pharmaceutical Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Hunan Nucien Pharmaceutical Co's Float Percentage Of Total Shares Outstanding is 0.00%.

Hunan Nucien Pharmaceutical Co Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Hunan Nucien Pharmaceutical Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hunan Nucien Pharmaceutical Co Institutional Ownership Chart

Hunan Nucien Pharmaceutical Co Historical Data

The historical data trend for Hunan Nucien Pharmaceutical Co can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 2.12 2.10 2.10 0.45 0.45 0.45 0.45 0.45 0.45 0.45
SHSE:688189
50GF Score
Hunan Nucien Pharmaceutical Co Ltd SHSE:688189
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hunan Nucien Pharmaceutical Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.45% mean?
Hunan Nucien Pharmaceutical Co (SHSE:688189) has a Institutional Ownership of 0.45% as of Aug. 31, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hunan Nucien Pharmaceutical Co and its competitors.
Is Hunan Nucien Pharmaceutical Co's Institutional Ownership too high?
Hunan Nucien Pharmaceutical Co's current Institutional Ownership is 0.45%. Overall, Hunan Nucien Pharmaceutical Co has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hunan Nucien Pharmaceutical Co's Institutional Ownership compare to ZTS?
Hunan Nucien Pharmaceutical Co's Institutional Ownership of 0.45% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Hunan Nucien Pharmaceutical Co and its competitors. Hunan Nucien Pharmaceutical Co's current Institutional Ownership is 0.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hunan Nucien Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co (SHSE:688189) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥2.30, compared to a current price of ¥6.74 — trading 193% above its estimated fair value. The current Institutional Ownership is 0.45%. Hunan Nucien Pharmaceutical Co's overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Hunan Nucien Pharmaceutical Co (SHSE:688189), the current Institutional Ownership is 0.45% as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hunan Nucien Pharmaceutical Co (SHSE:688189) Overvalued in 2026?

Based on GuruFocus' analysis, Hunan Nucien Pharmaceutical Co stock appears to be overvalued. The current stock price of ¥6.74 is trading 193% above its estimated GF Value™ of ¥2.30. GuruFocus considers Hunan Nucien Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for SHSE:688189:

  • Institutional Ownership: 0.45%
  • GF Value™: ¥2.30 vs. price of ¥6.74 (193% above fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688189 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hunan Nucien Pharmaceutical Co Business Description

Address No. 1 Kangli Road, Liuyang Economic and Technological Development Zone, Hunan Province, Changsha, CHN, 510100
Hunan Nucien Pharmaceutical Co Ltd is a pharmaceutical company integrating drug research and development, production and sales. The company focuses on anti-infection, cardio-cerebral vascular, anti-tumor and other pharmaceutical fields. The company's business scope includes the manufacturing and sales of chemical pharmaceutical preparations, chemical pharmaceutical raw materials, biological drugs, chemical reagents, and auxiliaries.
50GF Score

Get the complete analysis for SHSE:688189

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.74
Price
¥2.30
GF Value